Continuous Glucose Monitoring (CGM) Devices Market to Reach Valuation USD 1.1 billion by 2025

Continuous Glucose Monitoring (CGM)
Devices Market to Reach Valuation USD
1.1 billion by 2025 | Crystal Market
research
The latest trending report published by Crystal Market Research titled, Continuous Glucose Monitoring Devices
Market, approximates that the Continuous glucose monitoring (CGM) devices market size is estimated to
flourish at a significant CAGR in the future, and this is attributed to the escalation in need for this product across
the globe along with novel innovations in the market.
Get Sample Copy of the Report here: https://www.crystalmarketresearch.com/report-sample/HC0621
Continuous glucose monitoring (CGM) devices are used to measure glucose levels throughout the day and night.
A sensor is placed under the skin which measures the glucose level in tissue fluid. A transmitter is connected to
the sensor which transfers information via wireless radio frequency. This transmitter is connected to monitoring
and display device. Diabetes is a chronic disease which is classified into type 1 and type 2. Diabetes occurs either
when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin. The
1 | P a g e

symptoms of diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or
tingling sensation in hands or feet and increased hunger.
Market Scope:
North America held a major share of the overall market in 2015. This is attributed to factors such as high
predominance of diabetes, growing geriatric population, and improving reimbursement policies. U.S. dominated
the North American market owing to the presence of advanced healthcare infrastructure and high disposable
income of Americans. Asia-Pacific will bring in significant growth opportunities over the forecast period as the
awareness about patient monitoring systems is on the rise along with increased healthcare expenditure.
Key Findings of the Research Study:
Transmitters and receivers segment held the largest share of the global CGM devices market in 2016.
Insulin pumps segment will grow with the highest CAGR over the forecast period; these are highly
recommended over multiple daily injections for most patients suffering from type 1 diabetes.
North America held a major share of the global market in 2016, due to the presence of large patient base
and increasing demand for advanced patient monitoring systems.
Asia-Pacific is expected to grow at the highest CAGR throughout the forecast period. This is attributed to
factors such as the increasing prevalence of diabetes, sedentary lifestyle, and increasing patient awareness
about benefits of CGM devices with rise in disposable income of people.
Speak to Experts for any Queries: https://www.crystalmarketresearch.com/send-an-enquiry/HC0621
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one
stop solution for market research, business intelligence, and consulting services to help clients make more
informed decisions. It provides both syndicated as well as customized research studies for its customers spread
across the globe. The company offers market intelligence reports across a broad range of industries including
healthcare, chemicals & materials, technology, automotive, and energy.
Contact Us:
Email: sales@crystalmarketresearch.com
Website: http://www.crystalmarketresearch.com
2 | P a g e